Thursday, December 12, 2024

 Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully-integrated modelling study


PLOS

India could see more than 62.4 million cases of tuberculosis in the two decades to 2040, with scaling-up of existing treatment regimens potentially generating at least US$28 billion in GDP gains 

image: 

Researchers model cases of tuberculosis in India over the next two decades.

view more 

Credit: nonmisvegliate, Pixabay (CC0, https://creativecommons.org/publicdomain/zero/1.0/)



India could see more than 62.4 million cases of tuberculosis in the two decades to 2040, with scaling-up of existing treatment regimens potentially generating at least US$28 billion in GDP gains

 

#####

In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicinehttp://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004491 

Article Title: Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully-integrated modelling study

Author Countries: United Kingdom, Denmark

Funding: This work was funded by Johnson and Johnson, New Brunswick, NJ, USA, agreement number 2110-5191. All authors received this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

No comments:

Post a Comment